CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CLD HEALTH OUTCOMES
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Publications Webcasts Abstract Library Committee Members
 
 
NASH | Slide Library
Resource Library
 
   Released: 2023
test
Advances in NAFLD/NASH
Kris V. Kowdley, MD
55 slides
 
 
   Released: 2022
test
 
   Released: 2022
test
 
   Released: 2022
test
Pearls and Pitfalls: Update on emerging therapies in NASH
Michael Charlton, MD & Rohit Loomba, MD
97 slides
 
 
   Released: 2021
test
The Puzzle in Hepatorenal Syndrome Management
Hugo E. Vargas, MD
40 slides
 
 
   Released: 2021
test
COVID-19 and Managing Liver Disease
K. Rajender Reddy, M.D.
33 slides
 
 
   Released: 2021
test
Alcohol-Associated Liver Disease
Michael R. Lucey MD
43 slides
 
 
   Released: 2021
test
Chronic Hepatitis B and D: Emerging Concepts and Treatment
Robert G Gish MD, FAASLD, AGAF, FAST
42 slides
 
 
   Released: 2021
test
Management of Refractory Hepatic Encephalopathy
Jasmohan S. Bajaj, MD
41 slides
 
 
   Released: 2021
test
Hepatitis C: Elimination Strategies in the US
David Bernstein, MD, FAASLD, FACG, FACP, AGAF
43 slides
 
 
   Released: 2021
test
Management of Hepatocellular Carcinoma in 2021
Laura Kulik, MD
45 slides
 
 
   Released: 2021
test
Hot Topics In Pediatric Liver Disease
Rohit Kohli, MBBS, MS
35 slides
 
 
   Released: 2021
test
Thrombocytopenia in CLD
Robert S. Brown, Jr., MD, MPH
32 slides
 
 
   Released: 2021
test
Cholestatic Liver Disease: Current Management and Emerging Therapies
Kris V. Kowdley MD
36 slides
 
 
   Released: 2021
test
Emerging Therapies in NASH
Stephen A Harrison, MD, FACP, FAASLD
32 slides
 
 
   Released: 2021
test
Identifying High Risk NASH Patients Using Noninvasive Techniques (NITs)
Mazen Noureddin, MD, MHSc
42 slides
 
 
   Released: 2021
test
Burden of NASH: Why Do We Need to Care?
21 slides
 
 
   Released: 2021
test
NASH Screening and Diagnosis in Primary Care and Endocrinology Practice Settings: The Role of NITs
52 slides
 
 
   Released: 2021
test
NASH Screening and Diagnosis in Specialty Clinics: The Role of Radiologic Modalities, Serum Fibrosis Tests and Algorithm
40 slides
 
 
   Released: 2021
test
Treatment Endpoints: Clinical vs Regulatory Endpoints
39 slides
 
 
   Released: 2021
test
Combination Therapies in NASH: What's Promising?
21 slides
 
 
   Released: 2021
test
Lifestyle Modification and Current Treatment Regimens for NAFLD
29 slides
 
 
   Released: 2021
test
New Targets for Emerging Therapies in NASH
26 slides
 
 
   Released: 2020
test
Imaging as an Outcome and Endpoint for Clinical Trials of NASH
29 slides
 
 
   Released: 2020
test
Clinical Management of NASH: Diet and Nutrition
41 slides
 
 
   Released: 2020
test
The Comprehensive Global Burden and Impact of NASH
32 slides
 
 
   Released: 2020
test
NAFLD and Cardiovascular Disease
43 slides
 
 
   Released: 2020
test
Imaging as an Outcome and Endpoint for Clinical Trials of NASH
29 slides
 
 
   Released: 2020
test
Challenges in Management and Clinical Trials of NASH in Children
26 slides
 
 
   Released: 2020
test
Weight Loss in NASH: Role of Weight Loss Medications and Surgery
17 slides
 
 
   Released: 2020
test
Why NASH and Exercise?
43 slides
 
 
   Released: 2020
test
Is Histologic Fibrosis Assessment an Appropriate Endpoint / Reference Standard for Clinical Trials?
25 slides
 
 
   Released: 2020
test
NASH and Diabetes Linkage: Where do we go from here?
42 slides
 
 
   Released: 2020
test
Serum Biomarkers and Clinical Algorithms in NASH: Utility in Clinical Trials and Clinical Practice
49 slides
 
 
   Released: 2020
test
Best Practices in NASH Management and Current Status of Drug Development
37 slides
 
 
   Released: 2020
test
Imaging as an Outcome and Endpoint for Clinical Trials of NASH
35 slides
 
 
   Released: 2020
test
NASH: Current Approach and When Will New Treatment Options Be Available?
39 slides
 
 
   Released: 2018
Webcast
NASH 2018
61 slides
 
 
   Released: 2016
Webcast
Get Ready for the Global Epidemic of NASH: Evolving Diagnosis and Treatment Strategies
66 slides
 
 
   Released: 2015
Webcast
Best of the Liver Summit: PBC, NAFLD/NASH and HCV
78 slides
 
 
   Released: 2015
Webcast
Hepatology Update: New Developments in PBC, NAFLD & NASH
77 slides
 
 
   Released: 2015
Webcast
THE LIVER SUMMIT
89 slides
 
 
 
 
 
 

HEPATITIS

HBV
HCV
HDV

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Webcasts
Slide Library
Abstract Library

CHOLESTATIC

PBC

HCC

Slide Library
Abstract Library

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Mission Statement
Board of Trustees
Embassy of Education
Board of Advisors/Faculty
2023 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2023 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.